Bonasanit en es it fr

Bonasanit Brand names, Bonasanit Analogs

Bonasanit Brand Names Mixture

  • No information avaliable

Bonasanit Chemical_Formula


Bonasanit RX_link

No information avaliable

Bonasanit fda sheet

Bonasanit msds (material safety sheet)

Bonasanit MSDS

Bonasanit Synthesis Reference

No information avaliable

Bonasanit Molecular Weight

169.178 g/mol

Bonasanit Melting Point

207 oC

Bonasanit H2O Solubility

2.2E+005 mg/L

Bonasanit State


Bonasanit LogP


Bonasanit Dosage Forms


Bonasanit Indication

For the treatment of vitamin B6 deficiency and for the prophylaxis of isoniazid-induced peripheral neuropathy.

Bonasanit Pharmacology

Vitamin B6 (pyridoxine) is a water-soluble vitamin used in the prophylaxis and treatment of vitamin B6 deficiency and peripheral neuropathy in those receiving isoniazid (isonicotinic acid hydrazide, INH). Vitamin B6 has been found to lower systolic and diastolic blood pressure in a small group of subjects with essential hypertension. Hypertension is another risk factor for atherosclerosis and coronary heart disease. Another study showed pyridoxine hydrochloride to inhibit ADP- or epinephrine-induced platelet aggregation and to lower total cholesterol levels and increase HDL-cholesterol levels, again in a small group of subjects. Vitamin B6, in the form of pyridoxal 5'-phosphate, was found to protect vascular endothelial cells in culture from injury by activated platelets. Endothelial injury and dysfunction are critical initiating events in the pathogenesis of atherosclerosis. Human studies have demonstrated that vitamin B6 deficiency affects cellular and humoral responses of the immune system. Vitamin B6 deficiency results in altered lymphocyte differentiation and maturation, reduced delayed-type hypersensitivity (DTH) responses, impaired antibody production, decreased lymphocyte proliferation and decreased interleukin (IL)-2 production, among other immunologic activities.

Bonasanit Absorption

Readily absorbed

Bonasanit side effects and Toxicity

Oral Rat LD50 = 4 gm/kg. Toxic effects include convulsions, dyspnea, hypermotility, diarrhea, ataxia and muscle weakness.

Bonasanit Patient Information

No information avaliable

Bonasanit Organisms Affected

Humans and other mammals